Brian P Eliceiri Selected Research

Brian P Eliceiri Research Topics

Disease

19	Neoplasms (Cancer) 12/2021 - 12/2002
16	Burns 10/2023 - 01/2009
15	Inflammation (Inflammations) 01/2022 - 08/2009
11	Wounds and Injuries (Trauma) 02/2024 - 09/2009
9	Esophageal Neoplasms (Esophageal Cancer) 01/2020 - 01/2011
7	Shock 01/2019 - 01/2009
6	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2002
5	Glioma (Gliomas) 02/2013 - 01/2005
3	Acute Lung Injury 01/2018 - 11/2014
3	Infections 04/2015 - 01/2011
2	Breast Neoplasms (Breast Cancer) 12/2021 - 06/2012
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2019 - 04/2010
2	Sepsis (Septicemia) 01/2019 - 01/2009
2	Lung Injury 04/2015 - 11/2014
2	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2014 - 01/2011
2	Carcinoma (Carcinomatosis) 02/2005 - 12/2002
1	Otitis Media 01/2022
1	Drug-Related Side Effects and Adverse Reactions 11/2021
1	Hearing Loss (Hearing Impairment) 11/2021
1	Prostatic Neoplasms (Prostate Cancer) 12/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Dementia (Dementias) 05/2018
1	Frontotemporal Dementia (Semantic Dementia) 05/2018
1	Alzheimer Disease (Alzheimer's Disease) 05/2018
1	Huntington Disease (Huntington's Disease) 05/2018
1	Acute-Phase Reaction 05/2018
1	Hemorrhagic Shock 01/2018
1	Mental Disorders (Mental Disorder) 06/2015
1	Schizophrenia (Dementia Praecox) 06/2015
1	Pneumonia (Pneumonitis) 04/2015
1	Brain Neoplasms (Brain Tumor) 02/2013
1	Glioblastoma (Glioblastoma Multiforme) 02/2013

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
9	SteamIBA 01/2022 - 09/2009
9	CytokinesIBA 12/2019 - 01/2014
7	salicylhydroxamic acid (SHAM)IBA 10/2023 - 04/2010
6	Peptides (Polypeptides)IBA 02/2015 - 01/2005
5	Amino Acids FDA Link 12/2019 - 01/2005
5	Tight Junction ProteinsIBA 08/2012 - 01/2009
3	fluorescein isothiocyanate dextranIBA 01/2022 - 04/2010
3	ChemokinesIBA 01/2020 - 01/2014
3	LigandsIBA 12/2019 - 02/2015
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2019 - 08/2012
3	Interleukin-6 (Interleukin 6)IBA 11/2016 - 11/2014
3	Messenger RNA (mRNA)IBA 04/2015 - 01/2011
3	OccludinIBA 08/2012 - 04/2010
3	Pentoxifylline (Trental)FDA LinkGeneric 12/2009 - 01/2009
2	Estrogens (Estrogen)FDA Link 12/2021 - 04/2006
2	RNA (Ribonucleic Acid)IBA 05/2018 - 01/2014
2	Toll-Like Receptor 4IBA 01/2018 - 04/2010
2	Interleukin-10 (Interleukin 10)IBA 11/2016 - 04/2015
2	IntegrinsIBA 04/2016 - 01/2005
2	LipopolysaccharidesIBA 12/2015 - 04/2015
2	Thrombin FDA Link 05/2015 - 02/2015
2	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2013 - 12/2010
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 06/2012 - 05/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 01/2009
2	Saline SolutionIBA 12/2009 - 01/2009
2	p38 Mitogen-Activated Protein KinasesIBA 12/2009 - 09/2009
2	DNA (Deoxyribonucleic Acid)IBA 08/2009 - 01/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2006 - 02/2005
1	TetraspaninsIBA 02/2024
1	Pancreatic Elastase (Elastase)IBA 11/2022
1	Complement System Proteins (Complement)IBA 11/2022
1	Fibrinolysin FDA Link 11/2022
1	SerpinsIBA 11/2022
1	AR-R 17779IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	endotoxin receptorIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2021
1	EpitopesIBA 12/2021
1	Cisplatin (Platino)FDA LinkGeneric 11/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	AcidsIBA 12/2019
1	Protein Sorting Signals (Signal Peptide)IBA 12/2019
1	Epidermal Growth Factor (EGF)IBA 12/2019
1	OligonucleotidesIBA 12/2019
1	Polyvinyl AlcoholIBA 10/2019
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2019
1	InterferonsIBA 05/2018
1	Interleukin-8 (Interleukin 8)IBA 11/2016
1	adhesion receptorIBA 04/2016
1	CPSI-121IBA 01/2016
1	Cholinergic ReceptorsIBA 06/2015
1	Chemotactic FactorsIBA 05/2015
1	Matrix Metalloproteinases (MMPs)IBA 04/2015
1	GhrelinIBA 11/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2013
1	Temozolomide (Temodar)FDA LinkGeneric 02/2013

Therapy/Procedure

12	Therapeutics 10/2019 - 12/2002
8	Vagus Nerve Stimulation 03/2017 - 06/2010
3	Resuscitation 01/2018 - 01/2009
2	Intravenous Injections 01/2018 - 02/2005
2	Laparotomy 01/2018 - 04/2015
2	Drug Therapy (Chemotherapy) 02/2013 - 05/2006
2	Intraperitoneal Injections 12/2009 - 09/2009
1	Electrodes (Electrode) 10/2019
1	Inhalation Anesthesia 04/2015
1	Oral Administration 02/2013